Company intelligence / Profile preview
Thomas Advanced Medical LLC
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
Overview
The company has completed a Phase 1 trial for PrimePro for COVID-19 and is currently in Phase 2 for Prime Msk Shot for cardiovascular disorders. They are also conducting a Phase 1/2 trial evaluating the safety, tolerability, and efficacy of regenerative therapy for various chronic and acute conditions.
- Therapeutic areas
- Men's HealthPulmonologyEndocrinologyImmunologyDermatologyRheumatologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Stem Cell TherapyMesenchymal Stem CellsRegenerative Therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Thomas Advanced Medical LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thomas Advanced Medical LLC.